Report overview
A deuterated drug is a small molecule medicinal product in which one or more of the hydrogen atoms contained in the drug molecule have been replaced by its heavier stable isotope deuterium. Because of the kinetic isotope effect, deuterium-containing drugs may have significantly lower rates of metabolism, and hence a longer half-life.
This report contains market size and forecasts of Deuterated Drugs in Global, including the following market information:
Global Deuterated Drugs Market Size 2024-2030, ($ millions)
The global Deuterated Drugs market is projected to reach US$ million by 2029.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Deuterated Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Deuterated Drugs Market, by Type, 2024-2030 ($ millions)
Global Deuterated Drugs Market Segment Percentages, by Type
Austedo
Zepsun
Others
Global Deuterated Drugs Market, by Application, 2024-2030 ($ millions)
Global Deuterated Drugs Market Segment Percentages, by Application
Huntington'S Disease (HD)
Tardive Dyskinesia (TD)
Cancer
Others
Global Deuterated Drugs Market, By Region and Country, 2024-2030 ($ Millions)
Global Deuterated Drugs Market Segment Percentages, by region and country
United States
Europe
Asia
China
Rest of World
Competitor Analysis
The report also provides analysis of leading market participants including:
Further, the report presents profiles of competitors in the market, key players include:
Teva
Suzhou Zelgen Biopharmaceuticals
Concert Pharmaceuticals
Vertex Pharmaceuticals
Hinova Pharma
Otsuka Pharmaceutical (Avanir)
Poxel SA (DeuteRx)
